期刊
TRENDS IN BIOTECHNOLOGY
卷 36, 期 11, 页码 1100-1103出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2018.05.001
关键词
-
资金
- Swedish Foundation for Strategic Environmental Research (Mistra) through the Mistra Biotech public research program
- French National Research Agency (ANR) through the Investments for the Future project GENIUS [ANR-11-BTBR-0006-GENIUS]
- Biotechnology and Biological Sciences Research Council (BBSRC) [BB/CSP1730/1, BB/P013511/1]
- BBSRC [BB/L017768/1, BBS/E/J/000PR9789, BBS/E/C/00004975, BB/N019466/1, BBS/E/W/0012843D] Funding Source: UKRI
Is the European Union (EU) regulatory framework for genetically modified organisms (GMOs) adequate for emerging techniques, such as genome editing? This has been discussed extensively for more than 10 years. A recent proposal from The Netherlands offers a way to break the deadlock. Here, we discuss how the proposal would affect examples from public plant research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
